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ABSTRACT
The polyherbal preparations reported here are traditionally used in Northern Nigeria for the 
treatment of wide range of illnesses. The aim of this study was to evaluate the acute toxicity 
potential of 70% ethanol extracts of forty polyherbal products by determining their median lethal 
dose (LD50) estimates intraperitoneally and orally using the Lorke’s method in mice. Overall 90% 
of the extracts indicated values that were either less toxic or slightly toxic intraperitoneally, while 
10 % had values that were practically non toxic using the same route. Oral administration of the 
extracts showed that 25% had values that were only slightly toxic while 75 % of the herbal 
products had median lethal dose values that were practically non toxic. From our results this could 
imply that most of the extracts tested may be safe for oral use and this could explain the 
continuous use of the polyherbal preparations by the local people in traditional management of 
various ailments in the Northern part of Nigeria.
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INTRODUCTION
Folklore or herbal medicine is gaining greater recognition in the developed countries and often represents the 
popular therapeutic system to which people are referred for their primary health care in the developing countries. 
Medicinal plants are the oldest known health-care products because people have been utilizing herbal medicine for 
the treatment, control and management of a variety of diseases since ancient times (Kong et al., 2003,). It is
generally presumed that herbal medicines are more effective and because of their natural source are free from 
undesirable side effect (Mbaka and Owolabi, 2011). This belief has led to serious abuse such as prolonged 
administration without appropriate dose monitoring thereby undermining the greater potential for adverse effect.
The extensive traditional use of plants as medicines has enabled those medicines with acute and obvious signs of 
toxicity to be well recognised and their use avoided. However, the premise that traditional use of a plant for perhaps 
many hundreds of years establishes its safety does not necessarily hold true (De Smet, 2004). The increase in the 
number of users as opposed to the scarcity of scientific evidence on the safety of medicinal plants has raised 
concerns regarding toxicity and detrimental effects of these remedies. In rural communities, the exclusive use of 
herbal drugs prepared and dispensed by herbalists without formal training in the drug formulation and preparation 
for disease treatment is still very common, thus there is the need for screening methods be established to ascertain 
the safety and efficacy of these herbal products (Ogbonnia et al., 2008). 
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Majority of the traditional herbal medicines used in Africa are provided by practitioners who live within the 
communities. They have been trusted over time and are often willing to assist the patients with their knowledge and 
skills, sometimes at minimal costs to the patients. Most of these herbal medicines are procured in their crude forms 
although some pharmaceutical prepackaged forms also exist and are available over the counter. Interestingly a
genuine interest in various traditional practices now exists among practitioners of modern medicine and growing 
number of practitioners of traditional, indigenous or alternative systems are beginning to accept and use some of the 
modern technology. This will help foster teamwork among all categories of health workers within the framework of 
primary health care.
In the determination of safety of drugs and herbal products for human consumption, toxicological evaluation is 
carried out in various experimental animals to predict toxicity and to provide guidelines for selecting a ‘safe’ dose 
for humans. The proof of safety of these medicines in animals should take precedence over establishing efficacy. 
Hence, this study sought to investigate the acute toxicity profiles of Forty (40) polyherbal preparations marketed by 
members of Kano State branch of National Association of Nigerian Traditional Medicine Practitioners (NANTMP)
through determination of the median lethal doses (LD50) in mice.
MATERIALS AND METHODS
Study Area: Kano State located in the northwest political zone of Nigeria (110 30’N, 80 30’E), has a total area of 
20,131 km2 and population of about 13 million people is divided into 44 local government areas (LGAs). A large 
number of traditional medicine practitioners practice in the state, some of which practice independently while others 
practice under the umbrella of a union. The National Association of Nigerian Traditional Medicine Practitioners 
(NANTMP) is one of such associations that have been recognized by the Government of Nigeria.  
Collection of Test Materials: Herbal products were collected from various local government areas across the state 
under the umbrella of the National Association of Nigerian Traditional Medicine Practitioners. Some of the products 
had their compositions made available. All products were powdered materials.
Preparation of Extracts: For each product tested, 50 g of the powdered material was weighed out and submerged 
in 250 ml 70% ethanol and left to macerate for 72 h with occasional shaking. After maceration the resultant mixture 
were filtered using Whatman filter paper (No.1) and the filtrates evaporated to complete dryness using water bath at 
500C (Aliyu et al., 2014). The resulting dry extracts were then weighed to determine the percentage yield for each 
product. Aliquot portions of the extracts were weighed and dissolved in distilled water for use in the study.
Experimental Animals: Adult Swiss albino mice (weight: 20 to 33 g) of both sexes were used for the experiments. 
The animals were obtained from the animal house of the Department of Pharmacology, Bayero University Kano-
Nigeria and maintained under normal laboratory conditions of humidity, temperature and light for 7 days prior to the 
experiment and allowed free access to food and water. All experiments performed on the laboratory animals in this 
study were approved by the Local Ethical Committee for animal experimentation in the Department of 
Pharmacology, Faculty of Clinical Sciences, Bayero University, Kano, Nigeria. 
Acute Toxicity Study (Median Lethal Dose (LD50) Determination): This was conducted in two phases using the 
method described by Lorke (1983). In the initial phase, mice were divided into 3 groups of three mice each and 
treated at doses of 10, 100 and 1000 mg/kg, respectively of each extract, intraperitoneally (i.p.). These were then 
observed for 24 h for signs of toxicity, including death. In the final phase, mice were divided into either 3 or 4 
groups of one mouse each depending on the result of the first phase and treated with each extract at the doses 
suggested by Lorke, respectively (Table 1). The LD
50 
was calculated from the results of the final phase as the square 
root of the product of the lowest lethal dose and the highest non-lethal dose, i.e., the geometric mean of the 
consecutive doses with 0 and 100% survival, respectively. The same procedure was used for the oral route of 
administration (p.o).
RESULTS
Percentage Yield: Twelve point five percent (5) of the herbal products had percentage yield between 1- 9, while 25 
% (10) had yields in the range of 10 – 19 %. A percentage yield of 20 – 35 was recorded for 62.5 % (25) of the test 
products (Table 2).
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Median Lethal Dose (LD50): The intraperitoneal LD50 values for the test products were within the range of 178 to > 
5,000 mg/kg body weight. Forty percent (16) had values ranging from 100 to 1,000 mg/kg body weight, while LD50
values in the range of 1,001 to 5,000 mg/kg body weight was recorded for 50 % (20) of the herbal preparations. 
Median lethal dose (LD50) values for 10 % (4) of the products were greater than 5,000 mg/kg body weight i.p (Table 
2). The oral LD50 values were between 1,256 to > 5,000 mg/kg body weight. Twenty five percent (10) of the herbal 
products had values up to 5,000 mg/kg body weight, while 75 % (30) had values greater than 5,000 mg/kg body 
weight p.o (Table 2).
             
Table 1: Suggested Doses in the Two Phases Using Lorke’s Method.
Doses in mg/kg body weight
Result of the initial investigation
Doses chosen for the second test                     (mg/kg 
body weight)
                  10                                 100                    1000
         0/3* 0/3 0/3 1,600 2,900 5,000
0/3 0/3 1/3 600 1,000 1,600 2,900
0/3 0/3 2/3 200 400 800 1,600
0/3 0/3 3/3 140 225 370 600
0/3 1/3 3/3 50 100 200 400
0/3 2/3 3/3 20 40 80 160
0/3 3/3 3/3 15 25 40 60
1/3 3/3 3/3 5 10 20 40
2/3 0/3 0/3 2 4 8 16
3/3 3/3 3/3 1 2 4 8
             * Number of Animals which died/ number of animals used
Table 2: LD50 Values of Forty (40) Polyherbal Preparations Marketed in Northern Nigeria
SN Product Name Product Composition % Yield LD50 mg/kg
    ( i.p)
LD50 mg/kg
   (p.o)
1 Urinary Disorder 
Formula
Equsetum arvense, Chondrus 
crispus, Arctostaphylus 
uvaursi
22.0 1,131 > 5000
2 Reharb (1000) Capsules 24.5 570 3,800
3 Asthmatic Herbal 
Powder
12.1 471 3,800
4 Habbuk Capsules 17.1 775 > 5000
5 Bawa Energetic 
Capsules
21.5 775 > 5000
6 Measles Formula Vitex cienkowski,Cuiera 
genkowski, Parkia leaf
10.7 1,265 > 5000
7 Hemorrhoids Formula Vitex cienkowski, Centaura 
calcitraps, Lanea acide
23.1 178 > 5000
8 Rheumatic Tea Formula Salix alba, Eucalyptus 
glubolus, Albizia chive
12.0 > 5000 > 5000
9 Breast Cancer Formula Fiscus platyphylla, Ximenia 
Americana, Sarcocephalus 
russegen
27.5 471 > 5000
10 Smar Capsules 20.7 1,200 > 5000
11 Girfa Powder 24.0 3,800 > 5000
12 Hypertension Formula Verbena offcinalis, 
Foeniculum vulgare, Hibiscus 
abelmoschus, Viscum album
31.0 > 5000 > 5000
13 Hepatitis Formula Berberis Spp, Tarxacum Spp, 
Verbena officinalis, Vitex 
ciekowski
27.0 > 5000 > 5000
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14 Tuberculosis Tea Anogeissus leocarpus, 
Glycyrrza Spp, Allium cepa, 
Equisetum arvense
32.0 3,800 > 5000
15 Diabetes Tea Formula Artemisia absithium, 
Trigonella foenum graecum, 
Viscum album, Momodica 
balsamina
25.0 2,154 > 5000
16 Taipoid Formula Rheum palmatum, Inula 
helenium, Parkia filicoidea
19.0 2,154 > 5000
17 Skin Cancer Formula Fiscus platyphyda, Parkia 
pilpcoidea, Carica papaya, 
Securida longependumculata
18.0 289 > 5000
18 Ulcer Tea Myric cerifera, Tusilago 
furfara, Glycyrrhiza glabra, 
Achillea millefilum
26.0 1,265 3,808
19 Impotence Formula Carthamus tinctorius, Turnera 
aphrodisaca, Similax 
officinalis
7.6 2,154 > 5000
20 Asthma Tea Ephedra sinensis, Euphorbia 
hirta, Anogeissus lerocarpus
7.6 3,808 > 5000
21 Stomach Cancer 22.7 775 3,808
22 Immunozin Capsules Gulera senegalensis, Allium 
sativum, Azadiracta indica, 
Balanites aegyptiaca
28.0 1,131 > 5000
23 Diarrhea & Vomiting 
Formula
23.0 775 3,808
24 B6 Formula Carthamus tinctorius, Turnera 
aphrodisaca, Similax 
officinalis
23.8 471 > 5000
25 Pile- Hemorrhoids 
Formula
Achilea millefolium, Quercus 
alba, Plantago major
35.0 471 > 5000
26 Ajingawa Stomach  
Formula
28.0 1,265 3,808
27 Sha’a Formula 24.0 283 3,808
28 Sherif Uba Formula 9.3 2,154 > 5000
29 Joje Powder 21.0 775 3,808
30 Champion Capsules Nauclea latifolia, Ageratum 
conyzoides, Cassia alata, 
Morida lucida
30.2 2,154 > 5000
31 Greba Powder 24.0 3,808 > 5000
32 Fortrezin Capsules Zingiber officinallis, Moringa 
oleifera, Momordica 
charantia, Boswella Odorata
30.0 2,154 > 5000
33 Gadaudine Formula 24.0 471 1,265
34 Sikla Formula 14.0 1,265 > 5000
35 Takadari Powder 16.4 3,808 > 5000
36 Madubiya Formula 18.3 566 2,154
37 Markazu Shifan 8.0 1,131 > 5000
38 Shajaratul- Mukarrama 11.5 775 > 5000
39 Shukura Herbal Tea 9.3 2,154 > 5000
40 Munazzil Powder 22.7 > 5000 > 5000
DISCUSSION
Acute systemic toxicity measures relative toxicological response of an experimental organism to single or brief 
exposure to a test substance (OECD, 2001).The assessment of acute toxicity of an unknown substance is the first 
step in toxicological investigation (Lorke, 1983). The most frequently used acute toxicity test involves the 
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determination of median lethal dose (LD50). The LD50 is a statistically derived expression of a single dose of a 
material that can kill 50 percent of animals. The value represents the amount of toxicant per unit weight of the 
animal, which will kill 50 percent of a particular population of the animal species exposed to the chemical within a 
specific time, usually 24 to 72 hours. The routes of administration and animal species used affect the median lethal 
dose. 
The LD50 determines the safety margin for any substance or chemical and hence the choice of dose for the study of 
the substance or chemical for any work. The smaller the LD50 value, the more toxic is the chemical. The opposite is 
also true: the larger the LD50 value, the lower the toxicity. A scale proposed by Lorke, (1983) roughly classifies 
substances according to their LD50 as follows: very toxic (LD50 < 1.0 mg/kg), toxic (LD50 up to 10 mg/kg), less toxic 
(LD50 up to 100 mg/kg), only slightly toxic (up to 1000mg/kg). Substances with LD50 values greater than 5,000 
mg/kg are practically non toxic.
The culture of the indigenous population, though compounded at times by poor accessibility to healthcare facilities, 
largely influences the people’s healthcare-seeking behavior. Traditional healers and herbalists are an integral part of 
the culture around parts of Africa (Sorsdahl et al., 2013). Despite the growing market demand for herbal medicines, 
there are still concerns associated with not only their use, but their safety. For majority of these products in use, very 
little is known about their active and/or toxic constituents. Toxicity testing can reveal some of the risks that may be 
associated with use of herbs, therefore avoiding potential harmful effects when used as medicine.
Herbal preparations could be contaminated with microbiological and foreign materials such as heavy metals, 
pesticides, residues or even aflatoxins. Contaminants when present in herbal preparation may produce prominent 
health defects underscoring the claimed safety. An increase in the morbidity and mortality associated with the use of 
herbal or traditional medicines has raised universal attention in the last few years (Bondaranayake, 2006). The 
substitution of toxic Aristolochia species in traditional Chinese medicines (TCM) has resulted in cases of serious 
renal toxicity and renal cancer in Europe, China and America (EMEA, 2005). The emergence of interactions 
between Hypericum perforatum (St John's wort) and certain prescription medicines has necessitated regulatory 
action world-wide. Serious cases of liver damage including a number of fatalities associated with the use of Piper 
methysticum (Kava) have led to restrictions on its use in many countries (O'Sullivan and Lum, 2005).
The need to evaluate the toxicity profile of some herbal preparation extracts was prompted by their widespread use 
in the management of various disorders in Northern Nigeria. This study has shown the diversity in the toxicity of the 
herbal products tested. The intraperitoneal median lethal doses of the tested extracts indicated that 40% were less 
toxic while 50 % were only slightly toxic. Ten percent (10 %) of the extracts were practically non toxic by this 
route.  
The oral LD50 of the herbal products showed that 25 % were only slightly toxic while 75 % had median lethal doses 
that were practically non toxic. Thus, our results has shown that the use of most of these herbal formula extracts may 
be relatively safe on acute exposure especially when administered orally which is the main route  employed by the 
practitioners. Most of the extracts are therefore not relatively harmful after single oral administration and this could 
explain the continuous use of the preparations by the local people in traditional management of various ailments in 
Northern part of Nigeria.
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